Segment Information and Concentration (Details) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues	$ 5,237,800	$ 5,758,600	$ 11,400,500	$ 9,775,200
Income (Loss) from Operations	(4,079,400)	(2,105,300)	(13,668,100)	(3,672,500)
Depreciation and Amortization	380,800	327,300	688,200	251,500
Benchtop Laboratory Equipment
Revenues	4,608,900	5,031,100	9,981,100	9,043,600
Foreign Sales	1,322,500	2,031,100	3,702,400	3,483,700
Income (Loss) from Operations	203,500	851,700	1,475,800	1,461,300
Assets	8,622,500	9,715,400	9,538,600	14,783,000
Long-lived Asset Expenditures	34,300	66,600	92,500	60,500
Depreciation and Amortization	50,100	46,600	96,300	103,100
Bioprocessing Systems
Revenues	628,900	727,500	1,419,400	731,600
Foreign Sales	478,200	521,500	1,101,400	684,600
Income (Loss) from Operations	(3,483,200)	(3,712,700)	(11,369,500)	(4,828,600)
Assets	5,174,600	10,064,500	5,077,500	8,735,100
Long-lived Asset Expenditures	220,200	163,300	732,100	196,900
Depreciation and Amortization	330,700	280,700	591,900	148,400
Corporate
Revenues	0	0	0	0
Foreign Sales	0	0	0	0
Income (Loss) from Operations	(902,300)	(508,200)	(1,650,400)	(1,341,400)
Assets	4,272,100	9,072,600	6,391,800	5,488,300
Long-lived Asset Expenditures	0	0	0	0
Depreciation and Amortization	0	0	0	0
Consolidated
Revenues	5,237,800	5,758,600	11,400,500	9,775,200
Foreign Sales	1,800,700	2,552,600	4,803,800	4,168,300
Income (Loss) from Operations	(4,137,000)	(3,369,200)	(11,544,100)	(4,708,700)
Assets	18,069,200	28,852,500	21,007,900	29,006,400
Long-lived Asset Expenditures	254,500	229,900	824,600	257,400
Depreciation and Amortization	$ 380,800	$ 327,300	$ 688,200	$ 251,500